Exchange Traded Concepts’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,556
Closed -$113K 1501
2025
Q1
$113K Sell
2,556
-2,153
-46% -$99.1K ﹤0.01% 1118
2024
Q4
$170K Hold
4,709
﹤0.01% 1026
2024
Q3
$151K Buy
4,709
+317
+7% +$11.8K ﹤0.01% 1067
2024
Q2
$165K Sell
4,392
-1,367
-24% -$57.5K ﹤0.01% 896
2024
Q1
$283K Buy
5,759
+436
+8% +$20.2K 0.01% 827
2023
Q4
$194K Buy
5,323
+1,350
+34% +$35.2K 0.01% 791
2023
Q3
$91.9K Sell
3,973
-999
-20% -$27.3K ﹤0.01% 930
2023
Q2
$130K Buy
+4,972
New +$131K ﹤0.01% 886

Other funds holding SWTX

Exchange Traded Concepts's SWTX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 2,556 shares — an estimated $113K sold.

Exchange Traded Concepts first reported a position in SWTX in Q2 2023 and held it in 8 quarters. The position peaked at $283K in Q1 2024. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 2,556 SpringWorks Therapeutics shares in Q2 2025, an estimated $113K.
  • Exchange Traded Concepts first reported a position in SpringWorks Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's SpringWorks Therapeutics position peaked at $283K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.